Login / Signup

Lipid profile with eslicarbazepine acetate and carbamazepine monotherapy in adult patients with newly diagnosed focal seizures: post hoc analysis of a phase III trial and open-label extension study.

Eugen TrinkaRodrigo RocamoraJoão ChavesMathias J KoeppStephan RüeggMartin HoltkampJoana MoreiraMiguel M FonsecaGuillermo Castilla-FernándezFábio Ikedo
Published in: Therapeutic advances in neurological disorders (2023)
ClinicalTrials.gov NCT01162460/NCT02484001; EudraCT 2009-011135-13/2015-001243-36.
Keyphrases
  • phase iii
  • open label
  • phase ii
  • clinical trial
  • newly diagnosed
  • phase ii study
  • study protocol
  • double blind
  • placebo controlled
  • combination therapy
  • squamous cell carcinoma